Clive Brealey
Impact in
- Clinical Biochemistry top 10%
- Paraoxonase enzyme and polymorphisms
-
- Neurogenetic and Muscular Disorders Research
Papers in
-
- Ion channel regulation and function 1
-
- Insect and Pesticide Research 3
- Co-authors
- C.H. Walker (2 shared papers)Brian C. Baldwin (1 shared paper)Michael Gillen (5 shared papers)Paul Martin (4 shared papers)David Lawrence (1 shared paper)Robert Elsby (2 shared papers)Stephen E. Clarke (1 shared paper)G. Gordon Gibson (1 shared paper)
- Journals
- British Journal of Clinical Pharmacology (1 paper)Biochimica et Biophysica Acta (BBA) - Bioenergetics (1 paper)Clinical Therapeutics (1 paper)Xenobiotica (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United KingdomUnited StatesSingapore
In The Last Decade
Clive Brealey
15 papers receiving 367 citations
Peers
Comparison fields: 5 of 71
- Clinical Biochemistry 58
- Genetics 54
- Neurology 68
- Pharmacology 37
- Biochemistry 24
Countries citing papers authored by Clive Brealey
This map shows the geographic impact of Clive Brealey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clive Brealey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clive Brealey more than expected).
Fields of papers citing papers by Clive Brealey
This network shows the impact of papers produced by Clive Brealey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clive Brealey. The network helps show where Clive Brealey may publish in the future.
Co-authors
The 25 scholars most cited alongside Clive Brealey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1980 | 118 | |
| 2 | RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. | 2001 | 58 |
| 3 | 2016 | 41 | |
| 4 | 2001 | 39 | |
| 5 | 1984 | 19 | |
| 6 | 1998 | 19 | |
| 7 | 1989 | 19 | |
| 8 | 2001 | 17 | |
| 9 | 2016 | 15 | |
| 10 | 2015 | 15 | |
| 11 | 1979 | 11 | |
| 12 | 1991 | 10 | |
| 13 | 2015 | 5 | |
| 14 | 1990 | 4 | |
| 15 | 2016 | 3 |
About Clive Brealey
Clive Brealey is a scholar working on Molecular Biology, Insect Science, Pharmacology, Genetics and Cellular and Molecular Neuroscience, having authored 15 papers that have together received 393 indexed citations. Recurring topics across this work include Insect and Pesticide Research (3 papers), Pesticide and Herbicide Environmental Studies (2 papers), Amyotrophic Lateral Sclerosis Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Pesticide Exposure and Toxicity (2 papers), Nitric Oxide and Endothelin Effects (1 paper), Neurogenetic and Muscular Disorders Research (1 paper) and Ion channel regulation and function (1 paper). The work is most often cited by research in Clinical Biochemistry (58 citations), Genetics (54 citations), Neurology (68 citations), Pharmacology (37 citations) and Biochemistry (24 citations). Clive Brealey has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include C.H. Walker, Brian C. Baldwin, Michael Gillen, Paul Martin, David Lawrence, Robert Elsby, Stephen E. Clarke, G. Gordon Gibson, Jeremy Pratt and Alain Boireau. Their work appears in journals such as British Journal of Clinical Pharmacology, Biochimica et Biophysica Acta (BBA) - Bioenergetics, Clinical Therapeutics, Xenobiotica and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.